Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 663, Issue 1-2, 2009, Pages 52-59

  Upadhyay, Rohit ^a   Jain, Meenu ^a   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer susceptibility; COX 2 gene polymorphisms; COX 2 haplotypes; Esophageal squamous cell carcinoma; Inflammatory pathway

Indexed keywords

CYCLOOXYGENASE 2;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TUMOR LOCALIZATION;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 63549142903     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.01.007     Document Type: Article

References (40)

1. Hla T., Bishop-Bailey D., Liu C.H., Schaefers H.J., and Trifan O.C. Cyclooxygenase-1 and -2 isoenzymes. Int. J. Biochem. Cell Biol. 31 (1999) 551-557
2. Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta 1299 (1996) 125-140
3. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., and Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59 (1999) 198-201
4. Shamma A., Yamamoto H., Doki Y., Okami J., Kondo M., Fujiwara Y., Yano M., Inoue M., Matsuura N., Shiozaki H., and Monden M. Upregulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin. Cancer Res. 6 (2000) 1229-1238
5. Tazawa R., Xu X.M., Wu K.K., and Wang L.H. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem. Biophys. Res. Commun. 203 (1994) 190-199
6. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., and Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221 (1994) 889-897
7. Papafili A., Hill M.R., Brull D.J., McAnulty R.J., Marshall R.P., Humphries S.E., and Laurent G.J. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1631-1636
8. Szczeklik W., Sanak M., and Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J. Allergy Clin. Immunol. 114 (2004) 248-253
9. Zhang X., Miao X., Tan W., Ning B., Liu Z., Hong Y., Song W., Guo Y., Zhang X., Shen Y., Qiang B., Kadlubar F.F., and Lin D. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129 (2005) 565-576
10. Cok S.J., and Morrison A.R. The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J. Biol. Chem. 276 (2001) 23179-23185
11. Guo Y., Zhang X., Tan W., Miao X., Sun T., Zhao D., and Lin D. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Pharmacogenet. Genomics 17 (2007) 197-205
12. Moons L.M., Kuipers E.J., Rygiel A.M., Groothuismink A.Z., Geldof H., Bode W.A., Krishnadath K.K., Bergman J.J., van Vliet A.H., Siersema P.D., and Kusters J.G. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma. Am. J. Gastroenterol. 102 (2007) 2373-2379
13. Upadhyay R., Jain M., Kumar S., Ghoshal U.C., and Mittal B. Potential influence of interleukin-1 haplotype IL-1beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum. Immunol. 69 (2008) 179-186
14. Upadhyay R., Jain M., Kumar S., Ghoshal U.C., and Mittal B. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin. Immunol. 128 (2008) 199-204
15. Jain M., Kumar S., Rastogi N., Lal P., Ghoshal U.C., Tiwari A., Pant M.C., Baiq M.Q., and Mittal B. GSTT1, GSTM1, GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett. 242 (2006) 60-67
16. Hu Z., Miao X., Ma H., Wang X., Tan W., Wei Q., Lin D., and Shen H. A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48 (2005) 11-17
17. S. Schneider, D. Roessli, L. Excoffier, Arlequin ver. 2.00. Software for population genetics data analysis, Genetics and Biometry Laboratory, University of Geneva, Switzerland, 2000.
18. Jain M., Kumar S., Lal P., Tiwari A., Ghoshal U.C., and Mittal B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 178-181
19. Sanak M., Szczeklik W., and Szczeklik A. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. J. Allergy Clin. Immunol. 116 (2005) 221-223
20. Nozoe T., Ezaki T., Kabashima A., Baba H., and Maehara Y. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Am. J. Surg. 189 (2005) 110-115
21. Ferguson H.R., Wild C.P., Anderson L.A., Murphy S.J., Johnston B.T., Murray L.J., Watson R.G., McGuigan J., Reynolds J.V., and Hardie L.J. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 727-731
22. Saxena A., Prasad K.N., Ghoshal U.C., Bhagat M.R., Krishnani N., and Husain N. Polymorphism of -765G>C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H. pylori infection: a study from northern India. World J. Gastroenterol. 14 (2008) 1498-1503
23. Pereira C., Sousa H., Ferreira P., Fragoso M., Moreira-Dias L., Lopes C., Medeiros R., and Dinis-Ribeiro M. -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J. Gastroenterol. 12 (2006) 5473-5478
24. Ulrich C.M., Whitton J., Yu J.H., Sibert J., Sparks R., Potter J.D., and Bigler J. PTGS2 (COX-2) -765G>C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 616-619
25. Xing L.L., Wang Z.N., Jiang L., Zhang Y., Xu Y.Y., Li J., Luo Y., and Zhang X. Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index. World J. Gastroenterol. 14 (2008) 1785-1789
26. Tan W., Wu J., Zhang X., Guo Y., Liu J., Sun T., Zhang B., Zhao D., Yang M., Yu D., and Lin D. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 28 (2007) 1197-1201
27. Campa D., Zienolddiny S., Maggini V., Skaug V., Haugen A., and Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25 (2004) 229-235
28. Park J.M., Choi J.E., Chae M.H., Lee W.K., Cha S.I., Son J.W., Kim C.H., Kam S., Kang Y.M., Jung T.H., and Park J.Y. Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer 17 (2006) 70
29. Shen J., Gammon M.D., Terry M.B., Teitelbaum S.L., Neugut A.I., and Santella R.M. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res. 8 (2006) R71
30. Langsenlehner U., Yazdani-Biuki B., Eder T., Renner W., Wascher T.C., Paulweber B., Weitzer W., Samonigg H., and Krippl P. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. Clin. Cancer Res. 12 (2006) 1392-1394
31. Gallicchio L., Berndt S.I., McSorley M.A., Newschaffer C.J., Thuita L.W., Argani P., Hoffman S.C., and Helzlsouer K.J. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the riskof developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 6 (2006) 173
32. Cox D.G., Buring J., Hankinson S.E., and Hunter D.J. A polymorphism in the 3′ untranslated region of the gene encoding prostaglandinendoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res. 9 (2007) R3
33. Kawabe A., Shimada Y., Uchida S., Maeda M., Sato F., Itami A., and Imamura M. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 62 (2002) 46-54
34. von Rahden B.H., Stein H.J., Pühringer F., Koch I., Langer R., Piontek G., Siewert J.R., Höfler H., and Sarbia M. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res. 65 (2005) 5038-5044
35. Li M., Liu W., Zhu Y.F., Chen Y.L., Zhang B.Z., and Wang R. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer. Acta Oncol. 45 (2006) 1115-1119
36. Aoki T., Tsukinoki K., Kurabayashi H., Sasaki M., Yasuda M., Ota Y., Watanabe Y., and Kaneko A. Hepatocyte growth factor expression correlates with cyclooxygenase-2 pathway in human salivary gland tumorsk. Oral Oncol. 42 (2006) 51-56
37. Chang L.W., Chang Y.C., Ho C.C., Tsai M.H., and Lin P. Increase of carcinogenic risk via enhancement of cyclooxygenase-2 expression and hydroxyestradiol accumulation in human lung cells as a result of interaction between BaP and 17-beta estradiol. Carcinogenesis 28 (2007) 1606-1612
38. Wingender E., Chen X., Fricke E., Geffers R., Hehl R., Liebich I., Krull M., Matys V., Michael H., Ohnhauser R., Prub M., Schacherer F., Thiele S., and Urbach S. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29 (2001) 281-283
39. Sankaranarayanan R., Duffy S.W., Padmakumary G., Nair S.M., Day N.E., and Padmanabhan T.K. Risk factors for cancer of the oesophagus in Kerala, India. Int. J. Cancer. 49 (1991) 485-489
40. van Leeuwen D.M., van Agen E., Gottschalk R.W., Vlietinck R., Gielen M., van Herwijnen M.H., Maas L.M., Kleinjans J.C., and van Delft J.H. Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28 (2007) 691-697